Luminex Corp

Find Ratings Reports
LMNX : NASDAQ : Health Care
$19.81 | %
Today's Range: 0.0 - 0.0
Avg. Daily Volume: 184800.0
09/18/17 - 4:00 PM ET

Financial Analysis


LUMINEX CORP's gross profit margin for the second quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. LUMINEX CORP is extremely liquid. Currently, the Quick Ratio is 4.06 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 5.98% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)76.4664.17
EBITDA ($mil)13.6313.78
EBIT ($mil)7.989.51
Net Income ($mil)5.545.65


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)103.7181.72
Total Assets ($mil)458.95435.01
Total Debt ($mil)0.00.0
Equity ($mil)418.59394.96


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin70.0374.04
EBITDA Margin17.8321.48
Operating Margin10.4414.82
Sales Turnover0.650.57
Return on Assets3.089.47
Return on Equity3.3810.43
Debt Q2 FY17 Q2 FY16
Current Ratio5.74.79
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)43.2742.63
Div / share0.060.0
EPS0.130.13
Book value / share9.689.27
Institutional Own % n/a n/a
Avg Daily Volume185276.0229892.0

Valuation


HOLD. LUMINEX CORP's P/E ratio indicates a discount compared to an average of 66.42 for the Life Sciences Tools & Services industry and a significant premium compared to the S&P 500 average of 24.88. To use another comparison, its price-to-book ratio of 2.05 indicates a discount versus the S&P 500 average of 3.10 and a significant discount versus the industry average of 6.84. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. Upon assessment of these and other key valuation criteria, LUMINEX CORP proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
LMNX 61.94 Peers 66.42   LMNX 21.76 Peers 27.29

Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.

LMNX is trading at a valuation on par with its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

LMNX is trading at a discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
LMNX 27.72 Peers 30.86   LMNX 0.90 Peers 0.98

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

LMNX is trading at a premium to its peers.

 

Average. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

LMNX trades at a valuation on par to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
LMNX 2.05 Peers 6.84   LMNX -66.67 Peers 6.85

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

LMNX is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, LMNX is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
LMNX 2.88 Peers 11.02   LMNX 19.95 Peers 11.89

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

LMNX is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

LMNX has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades